13 September 2008

BI Solutions : Drug Safety using SAS® for Patient Safety

Business Intelligence BI Software Applications for Life Sciences - Drug Safety using SAS® for Patient Safety

A comprehensive safety solution featuring safety reporting, signal detection and root cause analysis in a single offering

Regulatory authorities, patients, healthcare professionals, government officials and the media are increasing their scrutiny of drug safety based on continuing, high-profile patient safety issues. Now more than ever, healthcare professionals and patients must continuously evaluate risks against benefits when making decisions about the right therapy.

SAS for Patient Safety is a comprehensive safety solution that features safety reporting, signal detection, and root cause analysis in a single offering. While less rigorous analytics work for certain applications, the critical nature of patient safety demands the best analytics available.

Benefits

  • Reduce your programming and validation efforts. Standard safety analyses address FDA guidance on drug safety information and leverage CDISC implementations that produce standard safety reports and provide the flexibility to adapt quickly to changing regulations.
  • Mitigate potential late-stage development failures and post-marketing risks. Identify and evaluate true pre-approval safety signals so you can make better, more informed drug development program decisions.
  • Efficiently produce PSUR submissions. SAS for patient safety lets you efficiently and comprehensively produce Periodic Safety Update Reports (PSURs) for submission to the FDA.
  • Achieve the highest level of post-approval safety reviews. Implement a standard set of signal detection algorithms and take a proactive approach to emerging post-market safety concerns.
  • Respond rapidly to inquiries and media events. SAS delivers the most complete scientific information available in order to minimize revenue erosion, protect shareholder value and maintain the public trust.

Source: Business intelligence BI software applications, SAS BI solutions for life sciences information at sas.com

BI Solutions : Drug Discovery & Development using SAS® Drug Development

Business Inteligence BI Software Applications - Drug Discovery & Development using SAS® Drug Development

Challenges ... Opportunities ... Now, more than ever, life sciences organizations are at a crossroads.

The key to overcoming industry challenges and capitalizing on new opportunities lies in an organization's ability to access relevant, accurate information that can be used to make informed business decisions with clarity and confidence. Enter SAS Drug Development.

SAS Drug Development provides a centralized, integrated system for managing, analyzing, reporting and reviewing clinical research information. The solution enables life sciences organizations to make informed business decisions with confidence, to assess the safety and efficacy of research compounds more effectively, to collaborate across trials, phases and therapeutic areas successfully, and ultimately get better products to market faster.

SAS Drug Development enables significant efficiency and productivity improvements within your R&D organizations, which translate into decreased development costs, a faster time-to-market and improved earnings.

Drawing on the power of the SAS®9 Intelligence Platform, SAS Drug Development specifically addresses the compliance requirements of life sciences organizations, while supporting your business objectives and aims to:

  • Integrate molecular information with clinical outcomes.
  • Deliver better therapies to market more quickly.
  • Control costs.
  • Comply with increasing regulatory requirements.
  • Collaborate globally.
  • Build a centralized, searchable repository of all research information.
  • Assess safety and efficacy more effectively.
  • Meet shareholder expectations.
  • Optimize efficiency and productivity across the life sciences value chain.

Source: Business intelligence BI software application, SAS BI solutions for life sciences information at sas.com

BI Solutions : SAS® for Clinical Data Integration

Business Intelligence BI Software Appolciation, BI Solutions for Life Sciences -SAS® for Clinical Data Integration

A complete environment for delivering full-spectrum clinical data integration capabilities
Inefficiencies in the collection, processing and analysis of clinical information slow the pace of drug development and can dramatically increase the cost of research and development. Many firms are leveraging data standards like CDISC to provide more efficient and effective use of clinical information.

SAS for Clinical Data Integration is the foundation you need to ensure standard, trusted clinical data. With SAS, you can gain both speed and efficiency by automating repeatable clinical data integration tasks.

Benefits

  • Build a single, integrated platform that lets you access and manage data from a wide range of sources—including EDC systems, in-house CDMSs, labs and CROs.
  • Identify and automate repeatable processes based on a common platform to reduce manual intervention, speed processes and improve decision making.
  • Ensure the proper use of standards by analyzing both the structure and the content of the data and using CDISC standards such as ODM and SDTM.
  • Provide an accurate, real-time view of the information by applying reliable data quality measures that let you address potential issues proactively before they have a negative impact on your study.

Source: Business intelligence BI software application, SAS BI solutions for life sciences information at sas.com

BI Solutions : SAS® Solutions for Life Sciences

Business Intelligence BI Software Applications : SAS® Solutions for Life Sciences

With so many challenges facing the life sciences industry – pricing pressures, pipeline pressures, impending patent expirations, the soaring cost of developing new drugs – the strength of these companies as well as the intellectual property they need to improve the health of the public is being threatened. While the focus seems to be shifting to personalized medicine – the right drug for the right patient – personalized drugs will most likely mandate significant changes to life sciences companies' business practices. How can drug companies remain profitable so they can continue to deliver the best drugs to the public?

SAS solutions for life sciences companies optimize the flow of valuable scientific and opera tional data within these companies – helping them bring therapies to market faster and more profitably. SAS is the only company that offers an end-to-end solution to drive efficiencies throughout every stage of a drug's lifecycle: from discovery, through development, commercialization and beyond.

SAS has a deep commitment to the development of data standards in life sciences. Anticipating the movement of the industry and its governing regulatory bodies toward standards, SAS has developed technology available today to support the emerging CDISC data models.

Globally recognized as the industry leader in analytics, the de facto standard for clinical data analysis, the FDA standard for electronic submissions and the choice of 100% percent of the Fortune 500 life sciences companies, SAS assures accurate, consistent and reliable analysis of pharmaceutical research data. By providing a way to warehouse, manage and analyze your data more efficiently and effectively, SAS solutions enable life sciences companies to:

  • Transform biomedical data into clinical insights quickly.
  • Analyze operational data to manage risk and maximize profits.
  • Convert intellectual property from discoveries into effective drug treatments.
  • Integrate scientific, customer, and operational data to make research and commercialization programs even more successful.

A suite of solutions to help bring your drug to market successfully
SAS understands that each stage of bringing a drug to market has unique needs. SAS Solutions for Life Sciences distinctly address the needs of each of these unique stages. Powered by SAS technology, SAS Solutions for Life Sciences are also designed to work collaboratively, enabling you to combine solutions as needed in order to bring your drug to market more quickly and successfully.

SAS® for Clinical Data Integration is the foundation you need to ensure standard, trusted clinical data. With SAS, you can gain both speed and efficiency by automating repeatable clinical data integration tasks.

SAS® Drug Development provides a centralized, integrated system for managing, analyzing, reporting and reviewing clinical research information. The solution enables life sciences organizations to get better products to market faster by more effectively assessing the safety and efficacy of research compounds and by facilitating collaboration across trials, phases and therapeutic areas.

SAS® for Patient Safety is a comprehensive safety solution that features safety reporting, signal detection, and root cause analysis in a single offering. While less rigorous analytics work for certain applications, the critical nature of patient safety demands the best analytics available.

SAS® for Life Sciences Sales and Marketing delivers unique customer insights that life sciences firms can use to execute more efficient marketing, sales and service strategies. SAS provides proven analytics to power sales and marketing execution.

Source: Business intelligence BI software application, SAS BI solutions for life sciences information at sas.com